Published 17 hours ago • loading... • Updated 6 hours ago
US FDA approves over-the-counter Tylenol combination pill for pain relief
The non-opioid tablet combines 650 mg of acetaminophen and 220 mg of naproxen sodium and can provide up to 12 hours of relief.
On Friday, the Food and Drug Administration approved an over-the-counter combination tablet of 650 mg of Tylenol and 220 mg of naproxen sodium. The opioid-free medication provides up to 12 hours of pain relief for adults and children aged 12 and older.
Kenvue developed the combination to simplify pain management after an estimated 75% of persistent pain sufferers reported dissatisfaction with current relief options. Eight clinical studies demonstrated the fixed-dose medication consistently outperformed either ingredient alone.
The medication begins working in under 30 minutes, but the FDA warned that labeling includes standard risks for NSAID-containing products including stomach bleeding and heart attack. Consumers should not use it with other acetaminophen drugs to avoid liver damage.
Kenvue confirmed the tablets will be available soon at major U.S. retailers, with the FDA granting the company a 3-year period of exclusivity for this new over-the-counter formulation.
Labeling advises pregnant women to consult a health professional and warns against use at 20 weeks or later in pregnancy. This follows past scrutiny by the Trump administration regarding prenatal acetaminophen use, which major medical organizations have contradicted.